Related Experiment Video
Updated: May 17, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
18β-Glycyrrhetinic acid inhibits methicillin-resistant Staphylococcus aureus survival and attenuates virulence gene
Danyelle R Long1, Julia Mead, Jay M Hendricks
1Department of Immunology and Infectious Diseases, Montana State University, Bozeman, Montana, USA.
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) has become a major source of infection in hospitals and in the community. Increasing antibiotic resistance in S. aureus strains has created a need for alternative therapies to treat disease. A component of the licorice root Glycyrrhiza spp., 18β-glycyrrhetinic acid (GRA), has been shown to have antiviral, antitumor, and antibacterial activity. This investigation explores the in vitro and in vivo effects of GRA on MRSA pulsed-field gel electrophoresis (PFGE) type USA300. GRA exhibited bactericidal activity at concentrations exceeding 0.223 μM. Upon exposure of S. aureus to sublytic concentrations of GRA, we observed a reduction in expression of key virulence genes, including saeR and hla. In murine models of skin and soft tissue infection, topical GRA treatment significantly reduced skin lesion size and decreased the expression of saeR and hla genes. Our investigation demonstrates that at high concentrations GRA is bactericidal to MRSA and at sublethal doses it reduces virulence gene expression in S. aureus both in vitro and in vivo.
Insights
18β-glycyrrhetinic acid (GRA) from licorice root shows potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). GRA also reduces MRSA virulence gene expression, offering a promising alternative therapy for infections.
Area of Science:
- Microbiology
- Pharmacology
- Natural Products Chemistry
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of hospital and community infections.
- Rising antibiotic resistance necessitates novel therapeutic strategies.
- 18β-glycyrrhetinic acid (GRA), a licorice root compound, possesses known antimicrobial properties.
Purpose of the Study:
- To investigate the in vitro and in vivo efficacy of GRA against MRSA.
- To evaluate GRA's impact on MRSA virulence factors.
Main Methods:
- In vitro testing of GRA against MRSA USA300.
- Analysis of virulence gene expression (saeR, hla) following GRA exposure.
- In vivo murine models of skin and soft tissue infection using topical GRA.
Main Results:
- GRA demonstrated bactericidal activity against MRSA at concentrations >0.223 μM.
- Sublytic GRA concentrations reduced the expression of saeR and hla virulence genes in vitro.
- Topical GRA significantly reduced lesion size and decreased virulence gene expression in vivo.
Conclusions:
- GRA exhibits bactericidal effects against MRSA at higher concentrations.
- GRA can attenuate MRSA virulence at sublethal doses, both in vitro and in vivo.
- GRA represents a potential therapeutic agent for MRSA infections, acting through both direct killing and virulence modulation.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibitors of Bacterial Protein Synthesis
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

